Yan M - Search Results

1

De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial.

Chen XC, Jiao DC, Qiao JH, Wang CZ, Sun XF, Lu ZD, Li LF, Zhang CJ, Yan M, Wei Y, Chen B, Feng YQ, Deng M, Ma MD, Plichta JK, He YW, Liu ZZ. Chen XC, et al. Among authors: yan m. Lancet Oncol. 2025 Jan;26(1):27-36. doi: 10.1016/S1470-2045(24)00581-3. Epub 2024 Nov 26. Lancet Oncol. 2025. PMID: 39612919 Clinical Trial.

2

Effect of the HER-2/CEP17 ratio in IHC 2+/FISH-amplified breast cancer on pathological complete response to neoadjuvant pertuzumab and trastuzumab treatment-a retrospective cohort study.

Wang J, Qiao J, Ruan Y, Wang C, Li L, Lu Z, Sun X, Zhang C, Chen X, Yan M, Cui S, Liu Z. Wang J, et al. Among authors: yan m. Gland Surg. 2022 Dec;11(12):1887-1896. doi: 10.21037/gs-22-632. Gland Surg. 2022. PMID: 36654959 Free PMC article.

3

Clinicopathological features and prognosis of breast cancer combined with symptomatic bone marrow metastases: A 10-year, single-center, real-world study of 67 cases.

Niu L, Lv H, Zhang M, Zeng H, Fu S, Cui S, Liu Z, Yan M. Niu L, et al. Among authors: yan m. Cancer Med. 2023 May;12(9):10672-10683. doi: 10.1002/cam4.5827. Epub 2023 Mar 23. Cancer Med. 2023. PMID: 36951543 Free PMC article.

4

Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Zhang P, Zhang Q, Tong Z, Sun T, Li W, Ouyang Q, Hu X, Cheng Y, Yan M, Pan Y, Teng Y, Yan X, Wang Y, Xie W, Zeng X, Wang X, Hu C, Geng C, Zhang H, Li W, Wu X, Zhong J, Xu J, Shi Y, Wei W, Bayaxi N, Zhu X, Xu B. Zhang P, et al. Among authors: yan m, yan x. Lancet Oncol. 2023 Jun;24(6):646-657. doi: 10.1016/S1470-2045(23)00172-9. Epub 2023 May 11. Lancet Oncol. 2023. PMID: 37182538 Clinical Trial.

5

A Nomogram for Identifying HR+/Her2- Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted Axillary Lymph Node Dissection Who Need Abemaciclib Therapy.

Yang H, Sun Y, Wang P, Qiao J, Li L, Lu Z, Sun X, Zhang C, Chen X, Yan M, Cui S, Wang C, Liu Z. Yang H, et al. Among authors: yan m. Med Sci Monit. 2023 Jul 16;29:e940124. doi: 10.12659/MSM.940124. Med Sci Monit. 2023. PMID: 37454245 Free PMC article.

6

Dalpiciclib and pyrotinib in women with HER2-positive advanced breast cancer: a single-arm phase II trial.

Yan M, Niu L, Lv H, Zhang M, Wang J, Liu Z, Chen X, Lu Z, Zhang C, Zeng H, Zhao S, Feng Y, Sun H, Li H. Yan M, et al. Nat Commun. 2023 Oct 7;14(1):6272. doi: 10.1038/s41467-023-41955-7. Nat Commun. 2023. PMID: 37805496 Free PMC article. Clinical Trial.

7

Neoadjuvant camrelizumab plus nab-paclitaxel and epirubicin in early triple-negative breast cancer: a single-arm phase II trial.

Wang C, Liu Z, Chen X, Qiao J, Lu Z, Li L, Sun X, Zhang C, Yue X, Xia Q, Zhang H, Yan M. Wang C, et al. Among authors: yan m. Nat Commun. 2023 Oct 20;14(1):6654. doi: 10.1038/s41467-023-42479-w. Nat Commun. 2023. PMID: 37863916 Free PMC article. Clinical Trial.

8

Effect of GnRH analogs in advanced male breast cancer: 10-year experience from the Henan Breast Cancer Center and literature review.

Zhang M, Lyu H, Niu L, Liu Z, Zeng H, Zhao S, Wang J, Sun H, Yan M. Zhang M, et al. Among authors: yan m. Chin Med J (Engl). 2024 Jul 5;137(13):1623-1625. doi: 10.1097/CM9.0000000000003005. Epub 2024 Mar 6. Chin Med J (Engl). 2024. PMID: 38445362 Free PMC article. No abstract available.

9

Dalpiciclib in combination with letrozole/anastrozole or fulvestrant in HR-positive and HER2-negative advanced breast cancer: results from a phase Ib study.

Zhang Q, Zhang P, Yan M, Yan X, Wang X, Gu Y, Qu X, Li S, Xu G, Zhu X, Xu B. Zhang Q, et al. Among authors: yan m, yan x. Ther Adv Med Oncol. 2024 Sep 2;16:17588359241273026. doi: 10.1177/17588359241273026. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39229468 Free PMC article.

10

Editorial: Treatment for advanced breast cancer with brain metastases.

Yan M, Yang J. Yan M, et al. Front Oncol. 2023 Sep 12;13:1268702. doi: 10.3389/fonc.2023.1268702. eCollection 2023. Front Oncol. 2023. PMID: 37771433 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,235 results

Search Page

Filters